New Patented GE Current Technology to Target Containing Airborne...
pharmatechoutlook

Pharma Tech Outlook: Pharma Tech Magazine

New Patented GE Current Technology to Target Containing Airborne Diseases

By Pharma Tech Outlook | Monday, September 28, 2020

GE Current has announced its new patent-pending technology that focuses on the inactivation of airborne viruses with the help of lighting that is always on.

FREMONT, CA: Developing its rich heritage of lighting and 365DisInFx technology that decreases the spread of bacteria, GE Current, a Daintree company, has announced its new patent-pending technology that focuses on the inactivation of airborne viruses with the help of lighting that is always on. These solutions signify the first line of defense that can fight against a wide range of germs, which also includes the SARS-CoV-2 virus around the clock.

According to Manish Bhandari, CEO, Current, “Our technology can be used in at-risk environments to reduce the potential spread of bacteria and viruses.Years of research in responsible usage of the ultraviolet spectrum has allowed us to develop a growing suite of solutions that promote wellness and can make a transformative impact on our lives during the pandemic and thereafter. As a trusted source for innovation, we’re counted on to adapt to emerging needs and are ready to help not just the health care community, but also to make these benefits available to broader public spaces where a disinfection strategy is essential.”

Bringing people back together

Since the pandemic still there even during the flu season, there is increasing urgency for a rigorous approach of disinfection in buildings, especially in crowded or densely populated areas. Current beliefs accelerating the return to similar routines need solutions that are always on. The solution must address the airborne risks and complement the proper wearing of a mask and manual cleaning of surfaces.

365DisInFx technology influences a business’s present lighting structure to deliver germicidal ultraviolet (UV) light in places where people gather. Therefore, current patented technology has demonstrated that it can decrease common pathogens on surfaces, although it is going through several application tests and end-user pilots. The products utilizing 365DisInFx technology currently aim to deliver a one-two punch that will target the bacteria on surfaces and viruses in the air 365 days a year.

 “Light can be a powerful ally in improving air quality by inactivating pathogens,” says Tom Boyle, Chief Technology Officer. “Specifically, LED is a solid-state lighting source allowing the spectral output to be engineered to enable features not feasible with legacy technologies. LEDs also excel at delivering light where it is needed and allow maximum flexibility when designing fixtures. UV-LED solutions change the paradigm of traditional disinfection lighting by making these benefits more accessible to more customers.”

Weekly Brief

Read Also